LITS logo

Lite Strategy, Inc. Stock Price

NasdaqCM:LITS Community·US$51.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

LITS Share Price Performance

US$1.39
-0.99 (-41.60%)
US$1.39
-0.99 (-41.60%)
Price US$1.39

LITS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with adequate balance sheet.

6 Risks
1 Reward

Lite Strategy, Inc. Key Details

US$0

Revenue

US$2.1m

Cost of Revenue

-US$2.1m

Gross Profit

US$9.5m

Other Expenses

-US$11.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.31
0%
0%
0%
View Full Analysis

About LITS

Founded
2000
Employees
4
CEO
Justin File
WebsiteView website
www.litestrategy.com

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Recent LITS News & Updates

Recent updates

No updates